MediciNova Total Liab vs Accounts Payable Analysis

MNOV Stock  USD 2.07  0.06  2.99%   
MediciNova financial indicator trend analysis is infinitely more than just investigating MediciNova recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MediciNova is a good investment. Please check the relationship between MediciNova Total Liab and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

Total Liab vs Accounts Payable

Total Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MediciNova Total Liab account and Accounts Payable. At this time, the significance of the direction appears to have almost no relationship.
The correlation between MediciNova's Total Liab and Accounts Payable is 0.16. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of MediciNova, assuming nothing else is changed. The correlation between historical values of MediciNova's Total Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of MediciNova are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Liab i.e., MediciNova's Total Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.16
Relationship DirectionPositive 
Relationship StrengthInsignificant

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Accounts Payable

An accounting item on the balance sheet that represents MediciNova obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MediciNova are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from MediciNova's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MediciNova current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.At this time, MediciNova's Tax Provision is fairly stable compared to the past year. Enterprise Value is likely to climb to about 82.8 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.7 M in 2024.
 2023 2024 (projected)
Extraordinary Items630K560K
Reconciled Depreciation20.3K18.7K

MediciNova fundamental ratios Correlations

1.0-0.750.380.90.820.00.760.550.57-0.860.170.890.450.980.90.24-0.49-0.090.560.990.9-0.22-0.51-0.51-0.67
1.0-0.710.40.910.8-0.050.740.490.55-0.850.160.90.40.990.90.26-0.51-0.080.541.00.9-0.23-0.53-0.45-0.64
-0.75-0.71-0.12-0.83-0.95-0.49-0.65-0.56-0.480.56-0.27-0.56-0.9-0.64-0.85-0.190.02-0.11-0.48-0.65-0.86-0.070.150.890.82
0.380.4-0.120.290.2-0.180.310.110.57-0.47-0.130.460.010.410.25-0.08-0.30.020.510.410.25-0.34-0.190.03-0.2
0.90.91-0.830.290.930.130.720.410.5-0.710.260.780.580.890.990.31-0.32-0.030.490.890.99-0.05-0.43-0.58-0.71
0.820.8-0.950.20.930.440.70.440.42-0.60.230.670.830.750.920.24-0.040.140.410.760.920.09-0.2-0.82-0.77
0.0-0.05-0.49-0.180.130.440.290.27-0.210.110.16-0.040.77-0.090.13-0.10.70.27-0.22-0.090.130.560.45-0.77-0.32
0.760.74-0.650.310.720.70.290.790.62-0.580.290.570.440.760.730.46-0.4-0.250.630.740.73-0.27-0.37-0.56-0.63
0.550.49-0.560.110.410.440.270.790.59-0.520.580.390.380.490.470.21-0.47-0.440.620.480.48-0.39-0.31-0.49-0.48
0.570.55-0.480.570.50.42-0.210.620.59-0.50.10.350.210.530.550.4-0.65-0.231.00.530.56-0.67-0.32-0.21-0.56
-0.86-0.850.56-0.47-0.71-0.60.11-0.58-0.52-0.5-0.28-0.92-0.26-0.85-0.730.120.540.18-0.49-0.86-0.730.260.420.30.61
0.170.16-0.27-0.130.260.230.160.290.580.1-0.280.220.170.180.29-0.11-0.31-0.520.120.150.29-0.18-0.27-0.20.04
0.890.9-0.560.460.780.67-0.040.570.390.35-0.920.220.30.910.77-0.16-0.41-0.150.330.910.77-0.1-0.51-0.36-0.49
0.450.4-0.90.010.580.830.770.440.380.21-0.260.170.30.310.590.050.380.320.20.330.590.330.17-0.96-0.68
0.980.99-0.640.410.890.75-0.090.760.490.53-0.850.180.910.310.870.26-0.55-0.170.521.00.87-0.24-0.57-0.38-0.59
0.90.9-0.850.250.990.920.130.730.470.55-0.730.290.770.590.870.27-0.36-0.060.550.871.0-0.08-0.44-0.61-0.74
0.240.26-0.19-0.080.310.24-0.10.460.210.40.12-0.11-0.160.050.260.27-0.31-0.030.410.260.27-0.32-0.17-0.07-0.23
-0.49-0.510.02-0.3-0.32-0.040.7-0.4-0.47-0.650.54-0.31-0.410.38-0.55-0.36-0.310.54-0.67-0.54-0.360.80.67-0.30.09
-0.09-0.08-0.110.02-0.030.140.27-0.25-0.44-0.230.18-0.52-0.150.32-0.17-0.06-0.030.54-0.26-0.11-0.070.340.51-0.2-0.08
0.560.54-0.480.510.490.41-0.220.630.621.0-0.490.120.330.20.520.550.41-0.67-0.260.520.55-0.68-0.34-0.22-0.56
0.991.0-0.650.410.890.76-0.090.740.480.53-0.860.150.910.331.00.870.26-0.54-0.110.520.87-0.25-0.55-0.39-0.6
0.90.9-0.860.250.990.920.130.730.480.56-0.730.290.770.590.871.00.27-0.36-0.070.550.87-0.09-0.44-0.61-0.74
-0.22-0.23-0.07-0.34-0.050.090.56-0.27-0.39-0.670.26-0.18-0.10.33-0.24-0.08-0.320.80.34-0.68-0.25-0.090.36-0.29-0.02
-0.51-0.530.15-0.19-0.43-0.20.45-0.37-0.31-0.320.42-0.27-0.510.17-0.57-0.44-0.170.670.51-0.34-0.55-0.440.360.00.07
-0.51-0.450.890.03-0.58-0.82-0.77-0.56-0.49-0.210.3-0.2-0.36-0.96-0.38-0.61-0.07-0.3-0.2-0.22-0.39-0.61-0.290.00.66
-0.67-0.640.82-0.2-0.71-0.77-0.32-0.63-0.48-0.560.610.04-0.49-0.68-0.59-0.74-0.230.09-0.08-0.56-0.6-0.74-0.020.070.66
Click cells to compare fundamentals

MediciNova Account Relationship Matchups

MediciNova fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets79.2M75.4M87.4M74.2M66.3M62.3M
Total Stockholder Equity74.9M71.3M83.7M70.2M62.4M50.9M
Retained Earnings(369.1M)(382.9M)(393.1M)(407.1M)(415.7M)(394.9M)
Other Assets59.8K5.0M97.9M92.8K106.7K101.4K
Common Stock Shares Outstanding43.2M44.4M48.6M49.0M49.0M24.6M
Liabilities And Stockholders Equity79.2M75.4M87.4M74.2M66.3M62.3M
Other Stockholder Equity444.0M454.3M476.8M477.4M478.1M331.0M
Total Liab4.3M4.1M3.7M3.9M3.9M3.7M
Other Current Liab1.8M1.6M2.3M2.6M2.1M1.6M
Total Current Liabilities2.2M2.2M2.8M3.2M3.3M4.5M
Property Plant And Equipment Net40.6K55.7K881.8K674.8K621.2K652.3K
Net Debt(63.4M)(59.9M)(71.3M)(18.3M)(50.8M)(48.2M)
Accounts Payable451.3K616.6K402.7K424.6K1.0M722.3K
Cash63.8M60.0M71.4M18.5M51.0M32.1M
Non Current Assets Total14.9M14.7M15.4M15.2M15.1M15.4M
Cash And Short Term Investments63.8M60.0M71.4M58.5M51.0M35.9M
Common Stock Total Equity43.9K45.0K49.0K49.0K56.4K31.3K
Non Current Liabilities Total2.1M1.9M896.5K725.4K612.5K581.8K
Other Current Assets511.9K680.2K578.0K499.4K174.9K166.2K
Property Plant And Equipment Gross40.6K55.7K1.3M1.1M1.1M1.1M
Total Current Assets64.3M60.7M72.0M59.0M51.2M38.1M
Common Stock43.9K45.0K49.0K49.0K56.4K32.4K
Other Liab1.9M1.9M1.9M201.8K232.1K220.5K
Non Currrent Assets Other459.8K246.2K115.5K92.8K74.2K70.4K
Accumulated Other Comprehensive Income(92.7K)(88.2K)(98.9K)(115.3K)(118.1K)(124.0K)
Property Plant Equipment40.6K55.7K57.6K45.3K40.7K38.7K
Short Long Term Debt Total399.3K184.8K132.0K157.5K215.9K205.1K
Net Tangible Assets65.3M61.7M74.1M60.6M69.7M41.2M
Retained Earnings Total Equity(369.1M)(382.9M)(393.1M)(407.1M)(366.4M)(384.7M)
Capital Surpluse444.0M454.3M476.8M477.4M549.1M427.3M
Net Invested Capital74.9M71.3M83.7M70.2M62.4M74.5M
Net Working Capital62.1M58.5M69.2M55.8M47.9M59.6M
Capital Stock43.9K45.0K49.0K49.0K56.4K51.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.